Synapse - Almedina Djesevic

Results (27)

Comprehensive genomic analysis of metastatic non–clear-cell renal cell carcinoma to identify therapeutic targets

Journal Article

Carlo, M. I.; Khan, N.; Zehir, A.; Patil, S.; Ged, Y.; Redzematovic, A.; Coskey, D. T.; Hyman, D. M.; Ladanyi, M.; Chen, Y. B.; more...
JCO Precision Oncology (2019)

Fulltext@MSK | Save

Systemic therapy for advanced clear cell renal cell carcinoma (ccRCC) after progression on immune-oncology plus VEGF targeted therapy combinations (IO-VEGF)

Meeting Abstract

Ged, Y.; Gupta, R.; Duzgol, C.; Shapnik, N.; Redzematovic, A.; Kotecha, R.; Voss, M. H.; Feldman, D. R.; Akin, O.; Patil, S.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Rates of occult brain metastases in patients (pts) with advanced renal cell carcinoma (RCC): A cohort study from patients treated across 22 clinical trials

Meeting Abstract

Kotecha, R.; Redzematovic, A.; Motzer, R. J.; Voss, M. H.
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Genomic biomarkers of response to nivolumab/ipilimumab (nivo/ipi) and nivolumab (nivo) monotherapy in 108 patients with advanced renal cell carcinoma

Meeting Abstract

Lee, C. H.; Di Natale, R. G.; Chowell, D.; Makarov, V.; Redzematovic, A.; Murray, S. J.; Carlo, M. I.; Voss, M. H.; Feldman, D. R.; Motzer, R. J.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Chromophobe renal cell carcinoma: Results from a large single-institution series

Journal Article

Casuscelli, J.; Becerra, M. F.; Seier, K.; Manley, B. J.; Benfante, N.; Redzematovic, A.; Stief, C. G.; Hsieh, J. J.; Tickoo, S. K.; Reuter, V. E.; more...
Clinical Genitourinary Cancer (2019)

Fulltext@MSK | Save

Characterization and impact of TERT promoter region mutations on clinical outcome in renal cell carcinoma

Journal Article

Casuscelli, J.; Becerra, M. F.; Manley, B. J.; Zabor, E. C.; Reznik, E.; Redzematovic, A.; Arcila, M. E.; Tennenbaum, D. M.; Ghanaat, M.; Kashan, M.; more...
European Urology Focus (2019)

Fulltext@MSK | Save

Metastatic chromophobe renal cell carcinoma: Presence or absence of sarcomatoid differentiation determines clinical course and treatment outcomes

Journal Article

Ged, Y.; Chen, Y. B.; Knezevic, A.; Casuscelli, J.; Redzematovic, A.; DiNatale, R. G.; Carlo, M. I.; Lee, C. H.; Feldman, D. R.; Patil, S.; more...
Clinical Genitourinary Cancer (2019)

Fulltext@MSK | Save

PTEN expression, not mutation status in TSC1, TSC2, or mTOR, correlates with the outcome on everolimus in patients with renal cell carcinoma treated on the randomized RECORD-3 trial

Journal Article

Voss, M. H.; Chen, D.; Reising, A.; Marker, M.; Shi, J.; Xu, J.; Ostrovnaya, I.; Seshan, V. E.; Redzematovic, A.; Chen, Y. B.; more...
Clinical Cancer Research (2019)

Fulltext@MSK | Save

Characterizing recurrent and lethal small renal masses in clear cell renal cell carcinoma using recurrent somatic mutations

Journal Article

Manley, B. J.; Reznik, E.; Ghanaat, M.; Kashan, M.; Becerra, M. F.; Casuscelli, J.; Tennenbaum, D.; Redzematovic, A.; Carlo, M. I.; Sato, Y.; more...
Urologic Oncology: Seminars and Original Investigations (2019)

Fulltext@MSK | Save

Single-center analysis of 109 patients (pts) with metastatic chromophobe renal cell carcinoma (ChRCC): Differences in outcomes by histologic variant

Meeting Abstract

Ged, Y.; Knezevic, A.; Chen, Y.; Redzematovic, A.; Carlo, M. I.; Lee, C. H.; Feldman, D. R.; Patil, S.; Motzer, R. J.; Voss, M. H.
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save